Alan D. Feiger
Impact in
- Pharmacology top 2%
- Treatment of Major Depression
- Biological Psychiatry top 10%
Papers in
- Pharmacology 10
- Treatment of Major Depression 10
-
- Electroconvulsive Therapy Studies 3
- Attention Deficit Hyperactivity Disorder 1
- Co-authors
- Richard L. Rudolph (1 shared paper)Ari Kiev (3 shared papers)Ram Shrivastava (4 shared papers)Charles S. Wilcox (2 shared papers)Joshua D. Lipsitz (3 shared papers)Karl Rickels (1 shared paper)Donald S. Robinson (1 shared paper)Moira A. Rynn (1 shared paper)
- Journals
- The Journal of Clinical Psychiatry (3 papers)International Clinical Psychopharmacology (3 papers)European Neuropsychopharmacology (2 papers)Biological Psychiatry (1 paper)CNS Spectrums (1 paper)
- Partner nations
- United StatesCanadaGermany
In The Last Decade
Alan D. Feiger
16 papers receiving 652 citations
Peers
Comparison fields: 5 of 65
- Pharmacology 406
- Biological Psychiatry 49
- Psychiatry and Mental health 266
- Experimental and Cognitive Psychology 132
- Cellular and Molecular Neuroscience 91
Countries citing papers authored by Alan D. Feiger
This map shows the geographic impact of Alan D. Feiger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alan D. Feiger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alan D. Feiger more than expected).
Fields of papers citing papers by Alan D. Feiger
This network shows the impact of papers produced by Alan D. Feiger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alan D. Feiger. The network helps show where Alan D. Feiger may publish in the future.
Co-authors
The 25 scholars most cited alongside Alan D. Feiger, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Nefazodone versus sertraline in outpatients with major depression: focus on efficacy, tolerability, and effects on sexual function and satisfaction. | 1996 | 149 |
| 2 | 1999 | 143 | |
| 3 | 1997 | 75 | |
| 4 | 2006 | 70 | |
| 5 | 1999 | 59 | |
| 6 | 2003 | 46 | |
| 7 | 2009 | 39 | |
| 8 | 1975 | 39 | |
| 9 | 2003 | 27 | |
| 10 | 2006 | 26 | |
| 11 | 2004 | 23 | |
| 12 | 2003 | 17 | |
| 13 | 1996 | 8 | |
| 14 | 2003 | 4 | |
| 15 | 1997 | 3 | |
| 16 | 2002 | 2 |
About Alan D. Feiger
Alan D. Feiger is a scholar working on Pharmacology, Psychiatry and Mental health, Clinical Psychology, Experimental and Cognitive Psychology and Statistics, Probability and Uncertainty, having authored 16 papers that have together received 730 indexed citations. Recurring topics across this work include Treatment of Major Depression (10 papers), Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (3 papers), Child and Adolescent Psychosocial and Emotional Development (3 papers), Electroconvulsive Therapy Studies (3 papers), Digital Mental Health Interventions (1 paper), Psychometric Methodologies and Testing (1 paper), Attention Deficit Hyperactivity Disorder (1 paper) and Neurotransmitter Receptor Influence on Behavior (1 paper). The work is most often cited by research in Pharmacology (406 citations), Biological Psychiatry (49 citations), Psychiatry and Mental health (266 citations), Experimental and Cognitive Psychology (132 citations) and Cellular and Molecular Neuroscience (91 citations). Alan D. Feiger has collaborated with scholars based in United States, Canada and Germany. Frequent co-authors include Richard L. Rudolph, Ari Kiev, Ram Shrivastava, Charles S. Wilcox, Joshua D. Lipsitz, Karl Rickels, Donald S. Robinson, Moira A. Rynn, Dan Zimbroff and Jon F. Heiser. Their work appears in journals such as The Journal of Clinical Psychiatry, International Clinical Psychopharmacology, European Neuropsychopharmacology, Biological Psychiatry and CNS Spectrums.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.